Inhibition of glucagon secretion by diphenylhydantoin in a patient with glucagonoma.
作者信息
Machina T, Marcus R, Levin S R
出版信息
West J Med. 1980 Apr;132(4):357-60.
Abstract
摘要
相似文献
1
Inhibition of glucagon secretion by diphenylhydantoin in a patient with glucagonoma.苯妥英对一名胰高血糖素瘤患者胰高血糖素分泌的抑制作用。
West J Med. 1980 Apr;132(4):357-60.
2
Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.疑似胰高血糖素瘤患者血浆胰高血糖素免疫反应性的分布
J Clin Endocrinol Metab. 1976 May;42(5):804-8. doi: 10.1210/jcem-42-5-804.
3
Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.一位胰高血糖素瘤患者血浆及肿瘤提取物中胰高血糖素的分泌反应和免疫化学异质性
Horm Res. 1986;23(3):159-66. doi: 10.1159/000180312.
4
[Inappropriate secretion of insulin by an islet cell adenoma. Trial treatment with diphenylhydantoin].[胰岛细胞瘤胰岛素分泌不当。苯妥英钠试验性治疗]
Ann Med Interne (Paris). 1976 May;127(5):403-7.
5
Clinical and metabolic aspects of glucagonoma.胰高血糖素瘤的临床和代谢方面
Medicine (Baltimore). 1980 Mar;59(2):100-13. doi: 10.1097/00005792-198003000-00002.
6
[Glucagonoma syndrome--a manifestation of neoplastic process].[胰高血糖素瘤综合征——肿瘤性病变的一种表现]
Przegl Dermatol. 1980 Sep-Oct;67(5):647-52.
7
[Benign insulinoma. Efficacy of preoperative treatment for persistent hyperinsulinemia using a synthetic somatostatin analog].
Minerva Endocrinol. 1994 Mar;19(1):33-7.
8
[Glucagonoma].[胰高血糖素瘤]
Horumon To Rinsho. 1971 Apr;19(4):321-5.
9
Enhanced glucose-dependent glucagon-like peptide-1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection.克罗恩病终末回肠病变患者中增强的葡萄糖依赖性胰高血糖素样肽-1和胰岛素分泌与疾病活动或回肠切除术无关。
Scand J Gastroenterol. 2004 Jul;39(7):650-6. doi: 10.1080/00365520410004839.
本文引用的文献
1
Determination of glucose by an improved enzymatic procedure.采用改进的酶法测定葡萄糖。
Clin Chem. 1961 Oct;7:542-5.
2
An immunochemical assay of total extractable insulin in man.人体中总可提取胰岛素的免疫化学测定。
J Clin Invest. 1960 Jul;39(7):1070-9. doi: 10.1172/JCI104122.
3
Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin.临床及脑电图与血清苯妥英水平的相关性
Arch Neurol. 1960 Jun;2:624-30. doi: 10.1001/archneur.1960.03840120030004.
4
[Care of the sick].[病人护理]
Ugeskr Laeger. 1956 Nov 8;118(45):1338-42.
5
Interpretation of the rapid intravenous glucose tolerance test in normal individuals and in mild diabetes mellitus.正常个体及轻度糖尿病患者快速静脉葡萄糖耐量试验的解读
J Clin Invest. 1953 May;32(5):428-35. doi: 10.1172/JCI102755.
6
Effect of diphenylhydantoin on insulin secretion in man.二苯乙内酰脲对人体胰岛素分泌的影响。
N Engl J Med. 1972 Feb 17;286(7):339-42. doi: 10.1056/NEJM197202172860702.
7
Molecular size of extractable glucagon and glucagon-like immunoreactivity (GLI) in plasma.血浆中可提取胰高血糖素及胰高血糖素样免疫活性物质（GLI）的分子大小
Diabetes. 1970 Sep;19(9):624-9. doi: 10.2337/diab.19.9.624.
8
Inhibition of insulin secretion by diphenylhydantoin in the isolated perfused pancreas.苯妥英对离体灌注胰腺胰岛素分泌的抑制作用。
J Clin Endocrinol Metab. 1970 Mar;30(3):400-1. doi: 10.1210/jcem-30-3-400.
9
In vitro inhibition of pancreatic glucagon secretion by diphenylhydantoin.苯妥英对胰腺胰高血糖素分泌的体外抑制作用。
J Clin Endocrinol Metab. 1972 Dec;35(6):823-4. doi: 10.1210/jcem-35-6-823.
10
Diphenylhydantoin. Its use in detecting early insulin secretory defects in patients with mild glucose intolerance.
Diabetes. 1973 Mar;22(3):194-201. doi: 10.2337/diab.22.3.194.
Zotero 插件